Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDUCE: Short-term vs Standard DAPT in ACS with COMBO Stent
NCT02118870Phase 4Completed
- Start
- Jun 2014
- Primary completion
- Sep 2017
01
Overview
Phase 4, randomised, open-label trial in acute coronary syndrome (ACS) (2 arms). Primary endpoint: Composite of all cause mortality, Myocardial Infarction (MI), Stent Thrombosis (ST), stroke, Target Vessel Revascularization (TVR) and bleeding (BARC II, III and V) at 360 days. Started Jun 2014; status: completed.
02
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02118870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118870.